(Q37696931)

22 August 2017

Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment (English)

1 reference

22 August 2017

0 references

1 reference

Victoria H Lawson

1

1 reference

22 August 2017

W David Arnold

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

5 April 2014

1 reference

Neuropsychiatric Disease and Treatment

22 August 2017

1 reference

22 August 2017

10

1 reference

22 August 2017

567-576

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

22 August 2017

start time

1 April 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Associated autoimmune diseases in patients with multifocal motor neuropathy and their family members

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Beneficial effect of rituximab monotherapy in multifocal motor neuropathy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Axon loss is an important determinant of weakness in multifocal motor neuropathy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Multifocal motor neuropathy: current concepts and controversies.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Peripheral neuropathies and anti-glycolipid antibodies

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Multifocal motor neuropathy.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Long term follow up of multifocal motor neuropathy with conduction block under treatment

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Multifocal motor neuropathy: response to human immune globulin

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Multifocal motor neuropathy with conduction block: a study of 24 patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Multifocal motor neuropathy: current therapies and novel strategies.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Immune pathogenesis and treatment of multifocal motor neuropathy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Sleep hypoventilation syndrome and respiratory failure due to multifocal motor neuropathy with conduction block.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Motor neuropathies and serum IgM binding to NS6S heparin disaccharide or GM1 ganglioside.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Bilateral phrenic neuropathy as a presenting feature of multifocal motor neuropathy with conduction block

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Multifocal motor neuropathy without overt conduction block

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

A syndrome of asymmetric limb weakness with motor conduction block

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

[Multifocal motor neuropathy: current review of epidemiology and treatment].

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Subcutaneous immunoglobulin therapy for multifocal motor neuropathy.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

IVIg dose increase in multifocal motor neuropathy: a prospective six month follow-up

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Pathophysiological heterogeneity of conduction blocks in multifocal motor neuropathy.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

How long is IVIg effective in multifocal motor neuropathy?

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Treatment of IgM antibody associated polyneuropathies using rituximab

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Axonal multifocal motor neuropathy without conduction block or other features of demyelination

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3983019

"Pseudo-conduction block" in vasculitic neuropathy

1 September 2018

1 reference

12 December 2020

Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone

1 reference

12 December 2020

Functioning of patients with multifocal motor neuropathy

1 reference

12 December 2020

Sensory loss in multifocal motor neuropathy: a clinical and electrophysiological study

1 reference

12 December 2020

Deterioration of multifocal motor neuropathy after plasma exchange

1 reference

12 December 2020

1 reference

12 December 2020

Rapidly progressive multifocal motor neuropathy with phrenic nerve paralysis: effect of nocturnal assisted ventilation

1 reference

12 December 2020

Multifocal motor neuropathy: the diagnostic spectrum and response to treatment

1 reference

12 December 2020

Multifocal motor neuropathy during treatment with infliximab

1 reference

12 December 2020

Acute neuropathy with multiple conduction blocks after TNFalpha monoclonal antibody therapy

1 reference

12 December 2020

[Improvement of severe and intravenous immunoglobulin-dependent multifocal motor neuropathy with conduction block after long-term rituximab]

1 reference

12 December 2020

Increased frequency of HLA-DRB1*15 in patients with multifocal motor neuropathy

1 reference

12 December 2020

Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy

1 reference

12 December 2020

1 reference

12 December 2020

Multifocal motor sensory demyelinating neuropathy: inflammatory demyelinating polyradiculoneuropathy

1 reference

12 December 2020

AAEM case report #30: multifocal motor neuropathy

1 reference

12 December 2020

[Multifocal motor neuropathy--unusual cause of hypoglossal palsy]

1 reference

12 December 2020

Neurological complications of infliximab

1 reference

12 December 2020

A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside

1 reference

12 December 2020

Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Guillain-Barré Syndrome Steroid Trial Group

1 reference

12 December 2020

Multifocal motor neuropathy mimicking motor neuron disease: nine cases

1 reference

12 December 2020

Multifocal motor neuropathy presenting with respiratory failure

1 reference

12 December 2020

Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome

1 reference

12 December 2020

Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome

1 reference

12 December 2020

"Pseudo-conduction block" in a patient with vasculitic neuropathy

1 reference

12 December 2020

Activity-dependent conduction block in multifocal motor neuropathy

1 reference

12 December 2020

Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment

1 reference

12 December 2020

Leukocyte and complement activation by GM1-specific antibodies is associated with acute motor axonal neuropathy in rabbits

1 reference

12 December 2020

Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment

1 reference

12 December 2020

Sensory nerve pathology in multifocal motor neuropathy

1 reference

12 December 2020

Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab

1 reference

12 December 2020

Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg

1 reference

12 December 2020

Natural history of 46 patients with multifocal motor neuropathy with conduction block

1 reference

12 December 2020

1 reference

12 December 2020

Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies--a prospective, multi-national study

1 reference

12 December 2020

Multifocal motor neuropathy with and without conduction block: A single entity?

1 reference

12 December 2020

Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy

1 reference

12 December 2020

Immunosuppressive treatment in multifocal motor neuropathy

1 reference

12 December 2020

IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN

1 reference

12 December 2020

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--first

1 reference

12 December 2020

Identifiers

DOI

10.2147/NDT.S39592

1 reference

22 August 2017

1 reference

22 August 2017

PubMed publication ID

24741315

1 reference